130 related articles for article (PubMed ID: 29076598)
21. Comparative Analysis of the Effects of Hydroxysafflor Yellow A and Anhydrosafflor Yellow B in Safflower Series of Herb Pairs Using Prep-HPLC and a Selective Knock-Out Approach.
Qu C; Wang LY; Jin WT; Tang YP; Jin Y; Shi XQ; Shang LL; Shang EX; Duan JA
Molecules; 2016 Nov; 21(11):. PubMed ID: 27827969
[TBL] [Abstract][Full Text] [Related]
22. Activation of PPARγ is required for hydroxysafflor yellow A of Carthamus tinctorius to attenuate hepatic fibrosis induced by oxidative stress.
Wang CY; Liu Q; Huang QX; Liu JT; He YH; Lu JJ; Bai XY
Phytomedicine; 2013 May; 20(7):592-9. PubMed ID: 23523101
[TBL] [Abstract][Full Text] [Related]
23. Restorative effects of hydroxysafflor yellow A on hepatic function in an experimental regression model of hepatic fibrosis induced by carbon tetrachloride.
Li Y; Shi Y; Sun Y; Liu L; Bai X; Wang D; Li H
Mol Med Rep; 2017 Jan; 15(1):47-56. PubMed ID: 27909717
[TBL] [Abstract][Full Text] [Related]
24. A novel oral preparation of hydroxysafflor yellow A base on a chitosan complex: a strategy to enhance the oral bioavailability.
Ma GN; Yu FL; Wang S; Li ZP; Xie XY; Mei XG
AAPS PharmSciTech; 2015 Jun; 16(3):675-82. PubMed ID: 25511808
[TBL] [Abstract][Full Text] [Related]
25. Hydroxysafflor yellow A inhibits rat brain mitochondrial permeability transition pores by a free radical scavenging action.
Tian J; Li G; Liu Z; Fu F
Pharmacology; 2008; 82(2):121-6. PubMed ID: 18583922
[TBL] [Abstract][Full Text] [Related]
26. Identification and mapping of a novel hydroxysafflor yellow A (HSYA) biosynthetic gene in Carthamus tinctorius.
Yang J; Wang Y; Guo ML
Biochem Genet; 2011 Jun; 49(5-6):410-5. PubMed ID: 21253824
[No Abstract] [Full Text] [Related]
27. Hydroxysafflor yellow A exerts antioxidant effects in a rat model of traumatic brain injury.
Wang Y; Zhang C; Peng W; Xia Z; Gan P; Huang W; Shi Y; Fan R
Mol Med Rep; 2016 Oct; 14(4):3690-6. PubMed ID: 27599591
[TBL] [Abstract][Full Text] [Related]
28. Hydroxysafflor Yellow A Promotes Angiogenesis via the Angiopoietin 1/ Tie-2 Signaling Pathway.
Chen T; Chen N; Pang N; Xiao L; Li Y; Li R; Luo M; Deng X; Ren M; Wu J; Wang L
J Vasc Res; 2016; 53(5-6):245-254. PubMed ID: 27894114
[TBL] [Abstract][Full Text] [Related]
29. Hydroxysafflor yellow A attenuates left ventricular remodeling after pressure overload-induced cardiac hypertrophy in rats.
Wang J; Zhang Q; Mei X; Zhang X
Pharm Biol; 2014 Jan; 52(1):31-5. PubMed ID: 24033225
[TBL] [Abstract][Full Text] [Related]
30. Hydroxysafflor yellow A, a natural compound from Carthamus tinctorius L with good effect of alleviating atherosclerosis.
Xue X; Deng Y; Wang J; Zhou M; Liao L; Wang C; Peng C; Li Y
Phytomedicine; 2021 Oct; 91():153694. PubMed ID: 34403879
[TBL] [Abstract][Full Text] [Related]
31. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
Liu YN; Zhou ZM; Chen P
Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):211-6. PubMed ID: 17941891
[TBL] [Abstract][Full Text] [Related]
32. Proteomic Analysis of Hydroxysafflor Yellow A Against Cerebral Ischemia/Reperfusion Injury in Rats.
Xu H; Liu T; Wang W; Su N; Yang L; Yang Z; Dou F; Cui J; Fei F; Ma J; Wen A; Ding Y
Rejuvenation Res; 2019 Dec; 22(6):503-512. PubMed ID: 30712471
[TBL] [Abstract][Full Text] [Related]
33. [Inhibitory action of hydroxysafflor yellow A on inflammatory signal transduction pathway related factors in rats with cerebral cortex ischemia].
Chen TT; Du YJ; Liu XL; Zhu HB
Yao Xue Xue Bao; 2008 Jun; 43(6):570-5. PubMed ID: 18822957
[TBL] [Abstract][Full Text] [Related]
34. Hydroxysafflor yellow A of Carthamus tinctorius attenuates lung injury of aged rats exposed to gasoline engine exhaust by down-regulating platelet activation.
Wang C; Wang C; Ma C; Huang Q; Sun H; Zhang X; Bai X
Phytomedicine; 2014 Feb; 21(3):199-206. PubMed ID: 24192212
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic effects of hydroxysafflor yellow A on focal cerebral ischemic injury in rats and its primary mechanisms.
Zhu HB; Zhang L; Wang ZH; Tian JW; Fu FH; Liu K; Li CL
J Asian Nat Prod Res; 2005 Aug; 7(4):607-13. PubMed ID: 16087635
[TBL] [Abstract][Full Text] [Related]
36. Enhancing effect of Labrafac Lipophile WL 1349 on oral bioavailability of hydroxysafflor yellow A in rats.
Wang S; Sun M; Ping Q
Int J Pharm; 2008 Jun; 358(1-2):198-204. PubMed ID: 18417306
[TBL] [Abstract][Full Text] [Related]
37. Mechanism of enhanced oral absorption of hydrophilic drug incorporated in hydrophobic nanoparticles.
Lv LZ; Tong CQ; Yu J; Han M; Gao JQ
Int J Nanomedicine; 2013; 8():2709-17. PubMed ID: 23935363
[TBL] [Abstract][Full Text] [Related]
38. Simultaneous determination of hydroxysafflor yellow A and ferulic acid in rat plasma after oral administration of the co-extractum of Rhizoma chuanxiong and Flos Carthami by HPLC-diode array detector.
Qi J; Jin X; Huang L; Ping Q
Biomed Chromatogr; 2007 Aug; 21(8):816-22. PubMed ID: 17441216
[TBL] [Abstract][Full Text] [Related]
39. [Protective effect of hydroxysafflor yellow A on experimental cerebral ischemia in rats].
Zhu HB; Wang ZH; Tian JW; Fu FH; Liu K; Li CL
Yao Xue Xue Bao; 2005 Dec; 40(12):1144-6. PubMed ID: 16496682
[TBL] [Abstract][Full Text] [Related]
40. [Inhibitory effect of hydroxysafflor yellow A against PMN activation induced by LPS].
Wu W; Jin M; Tong J; Wang XF; Zang BX
Yao Xue Xue Bao; 2011 Feb; 46(2):153-7. PubMed ID: 21542285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]